Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6

Transplantation

Volumn 72, Issue 4, 2001, Pages 720-726

  Cox, E Darrin ^a,b   Hoffmann, Steven C ^b   DiMercurio, Barbara S ^b   Wesley, Robert A ^b   Harlan, David M ^b   Kirk, Allan D ^a,b   Blair, Patrick J ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; RESTRICTION ENDONUCLEASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GENE CONTROL; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035959394     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108270-00027     Document Type: Article

References (62)

1. Cytokine genotypes in allograft rejection: Guidelines for immunosuppression
2. Influence of cytokine genotypes on allograft rejection
3. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
4. Genetic regulation of cytokine synthesis: Consequences for acute and chronic organ allograft rejection
5. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus
6. Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching
7. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production
8. Lymphocyte stimulation by CD3-CD28 enables detection of low T cell interferon-gamma and interleukin-4 production in rheumatoid arthritis
9. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
10. A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes
11. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus
12. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
13. Cytokine gene polymorphism and heart transplant rejection
14. Factors predicting perioperative cytokine response in patients undergoing liver transplantation
15. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
16. Effect of race on kidney transplants
17. Collaborative Transplant Study analysis of graft survival in blacks
18. Two novel biallelic polymorphisms in the IL-2 gene
19. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
20. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: A technical report
21. Race and end-stage renal disease
22. Clinical documentation of end-stage renal disease due to hypertension
23. An investigation of polymorphism in the interleukin-10 gene promoter
24. Interleukin-6 gene polymorphism and insulin sensitivity
25. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure
26. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men
27. Effect of HLA mismatch in African-Americans
28. Factors related to the donor organ are major determinants of renal allograft function and survival
29. Racial disparities in renal transplantoutcomes
30. Significance of tumor necrosis factor microsatellite polymorphism in renal transplantation
31. Tumor necrosis factor beta gene polymorphism and early primary kidney allograft loss
32. Lymphocyte responses and cytokines
33. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production
34. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells
35. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells
36. Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function
37. Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction
38. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection
39. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
40. Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a north European caucasoid group from the UK
41. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
42. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice
43. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy
44. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation
45. Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients
46. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study
47. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
48. Inflammatory markers in men with angiographically documented coronary heart disease
49. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
50. Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences
51. Cyclosporine bioavailability: Dosing implications and impact on clinical outcomes in select transplantation subpopulations
52. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability
53. Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients
54. Effect of race and immunosuppression in renal transplantation: Three-year survival results from a US multicenter, randomized trial: FKS06 Kidney Transplant Study Group
55. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine: FK506 Kidney Transplant Study Group
56. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study: Steroid Withdrawal Study Group
57. Tapering or discontinuing cyclo-sporine for financial reasons - A single-center experience
58. Racial disparities in renal transplant outcomes
59. Differential in situ expression of cytokines in renal allograft rejection
60. In vitro cytokine profiles and their relevance to rejection following renal transplantation
61. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts
62. Interferon-gamma receptor signaling is not required in the effector phase of the alloimmune response